Concomitant 5-ASA treatment does not affect efficacy, safety of vedolizumab in IBD

Press/Media

Period	17 Aug 2023

Media coverage

Title	Concomitant 5-ASA treatment does not affect efficacy, safety of vedolizumab in IBD
Media name/outlet	Healio
Country/Territory	United States
Date	17/08/23
URL	https://www.healio.com/news/gastroenterology/20230814/concomitant-5asa-treatment-does-not-affect-efficacy-safety-of-vedolizumab-in-ibd
Persons	Ryan Ungaro